# Hybrid Closure of Congenital Heart Disease

> **NCT02794584** · NA · COMPLETED · sponsor: **Nanjing Medical University** · enrollment: 200 (actual)

## Conditions studied

- Pediatric Ventricular Septal Defects

## Interventions

- **DRUG:** sufentanil anesthesia
- **PROCEDURE:** Hybrid closure
- **PROCEDURE:** Control

## Key facts

- **NCT ID:** NCT02794584
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02794584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02794584, "Hybrid Closure of Congenital Heart Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02794584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*